September 2025
1. NIERENGARTEN MB
   Neoadjuvant immunochemotherapy for nonsurgical HPV-negative head and neck cancer.
   Cancer. 2025;131:e70036.
   

   >> Share

   
   August 2025
2. BAI M, Lu Y, Shen L, Yin X, et al
   Anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) in patients with advanced esophageal squamous cell carcinoma: A multicenter, open-label, phase 1b clinical trial.
   Cancer. 2025;131:e70046.
   

   >> Share

   
   July 2025
3. NIERENGARTEN MB
   Active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer.
   Cancer. 2025;131:e35924.
   

   >> Share

   
   
4. HAUGEN CANGE H, Hogmo A, Sandstrom K, Wennerberg J, et al
   Radiotherapy or surgical treatment of early glottic carcinoma: A population-based study from the Swedish Head and Neck Cancer Register evaluating primary treatment outcomes for patients with T1a/T1b tumors.
   Cancer. 2025;131:e35955.
   

   >> Share

   
   April 2025
5. SAHIN O, Kamel S, Wahid KA, Dede C, et al
   International multispecialty expert physician preoperative identification of extranodal extension in patients with oropharyngeal cancer using computed tomography: Prospective blinded human inter-observer performance evaluation.
   Cancer. 2025;131:e35815.
   

   >> Share

   
   January 2025
6. KHANNA D, Mishra A, Birur P, Shruti T, et al
   A prospective study on diagnostic accuracy of technology-enabled early detection of oral cancer and epidemiology of tobacco and other substances use in rural India.
   Cancer. 2025;131:e35702.
   

   >> Share

   
   December 2024
7. NGUYEN T, Koric A, Chang CE, Barul C, et al
   Coffee and tea consumption and the risk of head and neck cancer: An updated pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.
   Cancer. 2024 Dec 23. doi: 10.1002/cncr.35620.
   

   >> Share

   
   
8. NIERENGARTEN MB
   First person profile: Quynh-Thu Le, MD: Dr Le confronts the difficult challenges of improving the efficacy and safety of radiation therapy in the treatment of head and neck cancers.
   Cancer. 2024;130:4164.
   

   >> Share

   
   
9. NIERENGARTEN MB
   Promising long-term disease control and survival with pembrolizumab and cabozantinib for head and neck cancer.
   Cancer. 2024;130:3947.
   

   >> Share

   
   
10. NIERENGARTEN MB
    Increased head and neck cancer linked to cannabis use.
    Cancer. 2024;130:3946.
    

    >> Share

    
    November 2024
11. DAY AT, Mitchell DN, Eary RL, Jones E, et al
    Considerations in screening for asymptomatic carotid artery stenosis in irradiated head and neck cancer survivors.
    Cancer. 2024 Nov 26. doi: 10.1002/cncr.35639.
    

    >> Share

    
    
12. BERZENJI D, Oude Booijink ORG, Gahrmann R, Mast H, et al
    A comprehensive approach to defining the cutoff value of oligometastasis in head and neck squamous cell carcinoma.
    Cancer. 2024 Nov 5. doi: 10.1002/cncr.35632.
    

    >> Share

    
    August 2024
13. WU Q, Hu C, Feng L, Yang X, et al
    Comprehensive genomic profiling of infiltrative follicular variant of papillary thyroid carcinoma.
    Cancer. 2024 Aug 14. doi: 10.1002/cncr.35517.
    

    >> Share

    
    July 2024
14. SALZ T, Meza AM, Bradshaw PT, Jinna S, et al
    Role of primary care in opioid prescribing for older head and neck cancer survivors.
    Cancer. 2024 Jul 27. doi: 10.1002/cncr.35478.
    

    >> Share

    
    June 2024
15. NIERENGARTEN MB
    First person profile: Everett Vokes, MD: Pioneer of the combination of radiation and chemotherapy as the first line of treatment for head and neck cancer.
    Cancer. 2024;130:2082-2083.
    

    >> Share

    
    
16. NIERENGARTEN MB
    FDA approves first immunotherapy drug for nasopharyngeal carcinoma.
    Cancer. 2024;130:1903.
    

    >> Share

    
    May 2024
17. NING T, Li D, Deng T, Bai Y, et al
    Anti-PD-L1 antibody TQB2450 combined with tyrosine kinase receptor inhibitor AL2846 for immunotherapy-refractory advanced hepatocellular carcinoma and esophageal squamous cell carcinoma: A prospective phase 1b cohort study.
    Cancer. 2024 May 23. doi: 10.1002/cncr.35377.
    

    >> Share

    
    
18. NIERENGARTEN MB
    First person profile: Barbara Burtness, MD: For more than 20 years, she has applied advances in molecular biology to better treat patients with head and neck cancers.
    Cancer. 2024;130:1724.
    

    >> Share

    
    March 2024
19. CONTRERA KJ, Patel MR, Burtness B, Mehra R, et al
    The role of surgery and deescalation for HPV-related oropharyngeal cancer.
    Cancer. 2024 Mar 18. doi: 10.1002/cncr.35287.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share